Our results demonstrate that genipin presents similar anti-metastatic effect by activating p38 MAPK to induce TIMP-1 expression in hepatocellular carcinoma, indicating that genipin may be on the list of potential therapeutic agents against human cancer. The gene discussed is TIMP1; the disease is hepatocellular carcinoma.